4 completed, 2 not yet recruiting, 2 recruiting, 1 approved for marketing. 3 Phase 2, 2 Phase 1, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Basal Cell Carcinoma (BCC): new trials by email Literature Review of Basal Cell Carcinoma (BCC) trials Research Report on Basal Cell Carcinoma (BCC)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Flash Radiotherapy for Skin Cancer FLASH radiotherapy, Conventional radiotherapy - Cutaneous Squamous Cell Carcinoma (CSCC), Basal Cell Carcinoma (BCC) | Phase 2 | Not yet recruiting | Jules Bordet Institute | 60 | 2026-06-23 | 2026-05-11 |
| Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence High-Frequency Ultrasound, Dermoscopy - Basal Cell Carcinoma of Skin, Cutaneous Squamous Cell Carcinoma (CSCC) | Not yet recruiting | Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji | 400 | 2025-12-23 | 2026-01-23 | |
| Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients Cemiplimab - Basal Cell Carcinoma (BCC), First Line Treatment | Phase 2 | Recruiting | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 34 | 2025-08-07 | 2026-03-11 |
| Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas aminolevulinic acid HCL (ALA), BLU-U device model 4170E - Basal Cell Carcinoma (BCC) | Phase 1 | Recruiting | Nathalie Zeitouni | 20 | 2024-10-07 | 2026-01-29 |
| Dose-Modulated Sonidegib Therapy for Periocular Basal Cell Carcinoma Sonidegib - Basal Cell Cancer, Eyelid Tumor | Completed | Federico II University | 12 | 2021-01-11 | 2025-07-16 | |
| Intraoperative Margin Assessment During Mohs Surgery Multimodal Spectroscopy (MMS) - Squamous Cell Carcinoma (SCC), Basal Cell Carcinoma (BCC) | Withdrawn | Seton Healthcare Family | 2016-10-01 | 2018-08-20 | ||
| Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy BF-200 ALA, methyl-aminolevulinate - Basal Cell Carcinoma (BCC) | Phase 3 | Completed | Biofrontera Bioscience GmbH | 281 | 2014-01-28 | 2022-11-03 |
| Intralesional Cryosurgery for Basal Cell Carcinoma - a Feasibility Study Intralesional cryotherapy - Basal Cell Carcinoma (BCC) | Not applicable | Unknown | Carmel Medical Center | 10 | 2012-07-01 | 2013-12-03 |
| Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas Itraconazole - Basal Cell Carcinoma (BCC), Skin Cancer | Phase 2 | Completed | Stanford University | 29 | 2010-04-01 | 2018-11-13 |
| A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer BMS-833923 (XL139) - Hedgehog Pathway, Smoothened | Phase 1 | Completed | Bristol-Myers Squibb | 53 | 2008-07-01 | 2014-08-15 |
| Expanded Access Use of Cemiplimab in Patients With Solid Tumors Cemiplimab - Non-Small Cell Lung Cancer (NSCLC), Basal Cell Carcinoma (BCC) | Approved for marketing | Regeneron Pharmaceuticals | 2025-11-20 |
Carcinoma, Basal Cell (11) · Skin Neoplasms (4) · Carcinoma, Squamous Cell (2) · Carcinoma, Non-Small-Cell Lung (1) · Eyelid Neoplasms (1) · Margins of Excision (1) · Neoplasms, Basal Cell (1) · Recurrence (1)
Carcinoma (11) · Neoplasms (11) · Neoplasms by Histologic Type (11) · Neoplasms, Glandular and Epithelial (11) · Neoplasms, Basal Cell (10) · Neoplasms by Site (6) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Neoplasms, Squamous Cell (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Disease Attributes (1) · Eye Diseases (1) · Eye Neoplasms (1) · Eyelid Diseases (1)
Aminolevulinic Acid (2) · cemiplimab (2) · BF-200 ALA (1) · BMS-833923 (1) · Dermoscopy (1) · Itraconazole (1) · methyl 5-aminolevulinate (1) · sonidegib (1)
Biofrontera Bioscience GmbH (1) · Bristol-Myers Squibb (1) · Carmel Medical Center (1) · Federico II University (1) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1) · Jules Bordet Institute (1) · Nathalie Zeitouni (1) · Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji (1) · Regeneron Pharmaceuticals (1) · Seton Healthcare Family (1) · Stanford University (1)
United States (3) · Germany (2) · Belgium (1) · Canada (1) · Israel (1) · Italy (1) · Poland (1)
Colin Morton, Dr. (1) · Diego Strianese, MD, PhD (1) · Jason Reichenberg, MD (1) · Jean Y Tang, MD (1) · Nathalie Zeitouni, MD (1) · Ralf Gutzmer, Prof. Dr. med. (1) · Rolf M. Szeimies, Prof. Dr. (1) · Salah-Eddin Al-Batran, Prof. Dr. med. (1) · Yaron Har-Shai, M.D (1)